Your browser doesn't support javascript.
loading
Could a Risk-adapted Approach Support Shared Decision-making Regarding Eligibility for Adjuvant Pembrolizumab for Patients with Clear Cell Renal Cell Carcinoma at High Risk of Recurrence? A Multicentre Cohort Study.
Campi, Riccardo; Pecoraro, Alessio; Roussel, Eduard; Amparore, Daniele; Mari, Andrea; Montorsi, Francesco; Porpiglia, Francesco; Albersen, Maarten; Capitanio, Umberto; Minervini, Andrea; Serni, Sergio; Bertolo, Riccardo.
Affiliation
  • Campi R; Unit of Urological Robotic Surgery and Renal Transplantation, Careggi Hospital, University of Florence, Florence, Italy; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Young Academic Urologists Renal Cancer Working Group, Arnhem, The Netherlands. Electroni
  • Pecoraro A; Unit of Urological Robotic Surgery and Renal Transplantation, Careggi Hospital, University of Florence, Florence, Italy.
  • Roussel E; Department of Urology, University Hospitals Leuven, Leuven, Belgium.
  • Amparore D; Division of Urology, Department of Oncology, School of Medicine, San Luigi Hospital, University of Turin, Orbassano, Italy.
  • Mari A; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Unit of Urological Oncologic Minimally Invasive Robotic Surgery and Andrology, Careggi Hospital, University of Florence, Florence, Italy.
  • Montorsi F; Division of Experimental Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy; University Vita-Salute San Raffaele, Milan, Italy.
  • Porpiglia F; Division of Urology, Department of Oncology, School of Medicine, San Luigi Hospital, University of Turin, Orbassano, Italy.
  • Albersen M; Department of Urology, University Hospitals Leuven, Leuven, Belgium.
  • Capitanio U; Division of Experimental Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy; University Vita-Salute San Raffaele, Milan, Italy.
  • Minervini A; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Unit of Urological Oncologic Minimally Invasive Robotic Surgery and Andrology, Careggi Hospital, University of Florence, Florence, Italy.
  • Serni S; Unit of Urological Robotic Surgery and Renal Transplantation, Careggi Hospital, University of Florence, Florence, Italy; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Bertolo R; Department of Urology, San Carlo Di Nancy Hospital, Rome, Italy.
Eur Urol Oncol ; 2023 Nov 07.
Article de En | MEDLINE | ID: mdl-37945489
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Eur Urol Oncol Année: 2023 Type de document: Article Pays de publication: Pays-Bas
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Eur Urol Oncol Année: 2023 Type de document: Article Pays de publication: Pays-Bas